VeloŔia™
Medicube TXA Niacinamide 15 Serum 30ml
Medicube TXA Niacinamide 15 Serum 30ml
Couldn't load pickup availability
Share
100% Authentic Beauty
Imported beauty products you can trust.
Cash on Delivery Orders
Pay when your order arrives..
Delivery Across Egypt
Fast delivery 1–3 business days..
Easy Exchange Policy
48-hour exchange policy..
Medicube TXA Niacinamide 15 Serum 30ml
Description
The Medicube TXA Niacinamide 15 Serum is a concentrated Korean brightening serum designed to improve the appearance of dark spots, post-acne marks, uneven skin tone, and rough texture. Formulated with 10% Niacinamide, 5% Tranexamic Acid (TXA), and Arbutin, it helps promote a brighter, clearer, and more even-looking complexion. Its hydrating formula also contains 10 types of Hyaluronic Acid, Panthenol, Betaine, and Glutathione to replenish moisture and support skin comfort. The lightweight, fragrance-free texture absorbs comfortably without a heavy feel, making it ideal as a dark spot serum for hyperpigmentation, acne marks, uneven skin tone, and dull skin سيروم مركز للتصبغات وآثار الحبوب وتوحيد لون البشرة مع ترطيب وتحسين ملمس البشرة.
Why you’ll love it
-
10% Niacinamide helps improve the appearance of uneven skin tone and texture.
-
5% Tranexamic Acid targets the appearance of dark spots and post-acne marks.
-
Arbutin supports brightening and more even-looking skin.
-
Glutathione provides antioxidant-focused skincare.
-
10 types of Hyaluronic Acid help maintain hydration and a plump-looking complexion.
-
Panthenol and Betaine help keep skin moisturized and comfortable.
-
Lightweight, fragrance-free formula designed for daily skincare.
Perfect for
All skin types, especially skin concerned with dark spots, post-acne marks, dullness, uneven skin tone, and rough texture.
The finish
Smooth, hydrated, brighter-looking skin with a fresh, balanced glow.
Veloria note
A Korean TXA and Niacinamide brightening serum combining 10% Niacinamide, 5% Tranexamic Acid, and Arbutin for targeted dark-spot care and a more even-looking complexion.







